Picture of Legend Biotech logo

LEGN Legend Biotech Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual income statement for Legend Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F/A20-F/A20-F/A20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue607568.8117285
Cost of Revenue
Gross Profit51.6141
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses194385469554813
Operating Profit-134-310-400-437-528
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-127-308-407-446-520
Provision for Income Taxes
Net Income After Taxes-102-266-404-446-518
Net Income Before Extraordinary Items
Net Income-102-266-404-446-518
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-102-266-404-446-518
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.508-1.13-1.43-1.4-1.47